CAU
SEM

Caxton Associates (UK)’s Select Medical SEM Stock Holding History

Caxton Associates (UK)’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-349,564
Closed -$5.69M – 950
2026
Q1 		$5.69M Buy
349,564
+331,807
+1,869% +$5.19M 0.13% 53
2025
Q4 		$264K Buy
+17,757
New +$251K 0.01% 647

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Caxton Associates (UK)'s SEM Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Select Medical (SEM) in Q2 2026, closing a stake of 349,564 shares — an estimated $5.69M sold.

Caxton Associates (UK) first reported a position in SEM in Q4 2025 and held it in 2 quarters. The position peaked at $5.69M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 349,564 Select Medical shares in Q2 2026, an estimated $5.69M.
  • Caxton Associates (UK) first reported a position in Select Medical in Q4 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Select Medical position peaked at $5.69M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.